Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000317233 | SCV000335800 | uncertain significance | not provided | 2015-10-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000317233 | SCV002049189 | uncertain significance | not provided | 2021-10-11 | criteria provided, single submitter | clinical testing | The WDR35 c.1260A>G; p.Thr420= variant (rs148828104) to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 283601). This variant is found in the African population with an allele frequency of 0.2% (45/24,854 alleles) in the Genome Aggregation Database. This is a synonymous variant in a weakly conserved nucleotide, but computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic donor splice site that is as strong as the native donor splice site downstream. Due to limited information, the clinical significance of the p.Thr420= variant is uncertain at this time. |
Invitae | RCV002059130 | SCV002380161 | likely benign | Cranioectodermal dysplasia 2; Short-rib thoracic dysplasia 7 with or without polydactyly | 2021-11-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003909951 | SCV004718483 | likely benign | WDR35-related condition | 2022-01-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |